ADA also effectively reduced the growth of colorectal carcinoma, melanoma cells, prostate cancer cells, and hepatoma cells (Ocker et al., 2004; Shi et al., 2015; Li et al., 2019; Nong et al., 2022). The gene discussed is ADA; the disease is prostate carcinoma.